Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 8/20 | 0.38 |
| ▸ | BCAT1 | P54687 | 8/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8193759 | 0.89 | BCAT2 (0.40) | BCAT2BCAT1AR | |
| SCHEMBL5848585 | 0.87 | BCAT1 (0.43) | BCAT2BCAT1 | |
| SCHEMBL3901986 | 0.86 | BCAT2 (0.38) | BCAT2BCAT1 | |
| SCHEMBL7166377 | 0.84 | BCAT2 (0.37) | BCAT2BCAT1 | |
| SCHEMBL7656343 | 0.84 | BCAT2 (0.37) | BCAT2BCAT1 | |
| SCHEMBL6703569 | 0.84 | BCAT1 (0.46) | BCAT2BCAT1AR | |
| SCHEMBL7951139 | 0.83 | BCAT2 (0.40) | BCAT2BCAT1AR | |
| SCHEMBL5847499 | 0.83 | BCAT2 (0.37) | BCAT2BCAT1 | |
| SCHEMBL9469470 | 0.82 | BCAT2 (0.39) | BCAT2BCAT1AR | |
| SCHEMBL7037750 | 0.82 | MAPT (0.36) | BCAT2BCAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040023805-A1 | Substituted phenyluracils | ANDREE ROLAND (DE) | 2004-02-05 | — | — | US | disclosed |
| US-6649760-B2 | Herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2003-11-18 | — | — | US | disclosed |
| US-20020173425-A1 | Substituted phenyluracils | BAYER AKTIENGESELLSCHAFT (DE) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173425-A1 | Substituted phenyluracils | DPYD, POP1, G6PD | BCAT2 505/4885BCAT1 655/4885XDH 659/4885 |
| US-20040023805-A1 | Substituted phenyluracils | DPYD, POP1, G6PD | BCAT2 505/4885BCAT1 655/4885XDH 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.